Signaling pathways
-
BA5530 BlarcamesineSummary: Blarcamesine is an agonist and muscarinic receptor modulator with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. -
BA5531 ML169Summary: ML169 (VU0405652) is a potent, selective, orthosteric modulator (PAM) that crosses the blood-brain barrier. -
BA5532 TerodilineSummary: Terodiline is an antispasmodic. -
BA5533 VelufenacinSummary: Antagonists of muscarinic-type receptors. -
BA5534 Nor-benzetimideSummary: Nor-benzetimide is the major metabolite of Benzetimide. -
BA5535 VU0486846Summary: An orally active muscarinic acetylcholine receptor-selective positive allosteric modulator (PAM). -
BA5536 ZINC49534341Summary: ZINC49534341 is an antagonist. -
BA5537 ML382Summary: ML382 is a potent and selective positive modulator of Mas-related G protein-coupled receptor X1. -
BA5538 AZD1979Summary: Antagonist. -
BA5539 CRN04894Summary: CRN04894 is an orally potent antagonist that exhibits in vivo potency in a rat model of adrenocorticotropic hormone (ACTH)-stimulated corticosterone secretion.

